Skip to Content
Merck
All Photos(2)

Documents

855775P

Avanti

18:0 Lyso PC

Avanti Polar Lipids

Synonym(s):

1-octadecanoyl-sn-glycero-3-phosphocholine; PC(18:0/0:0)

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C26H54NO7P
CAS Number:
19420-57-6
Molecular Weight:
523.68
UNSPSC Code:
51191904
NACRES:
NA.25

description

1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine

Assay

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

form

powder

packaging

pkg of 1 × 1 g (855775P-1g)
pkg of 1 × 200 mg (855775P-200mg)
pkg of 1 × 25 mg (855775P-25mg)
pkg of 1 × 500 mg (855775P-500mg)

manufacturer/tradename

Avanti Polar Lipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCCCC)=O

InChI

1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3

InChI key

IHNKQIMGVNPMTC-UHFFFAOYSA-N

Application

18:0 Lyso PC has been used:
  • to functionalize carbon nanotubes (CNTs) for the development of methods to attach DNA to CNTs
  • to increase the level of lysophosphatidic acid (LPA) in mouse
  • to induce TNF receptor associated factor 3 interacting protein 2 (TRAF3IP2) expression in endothelial cells (EC)

Packaging

20 mL Clear Glass Screw Cap Vial (855775P-1g)
20 mL Clear Glass Screw Cap Vial (855775P-500mg)
5 mL Amber Glass Screw Cap Vial (855775P-200mg)
5 mL Amber Glass Screw Cap Vial (855775P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators
Valente AJ, et al.
Free radical biology & medicine, 70, 117-128 (2014)
Optimising DNA binding to carbon nanotubes by non-covalent methods
Vanesa Sanz
Carbon, 49(5), 1775-1781 (2011)
Anthony J Valente et al.
Free radical biology & medicine, 70, 117-128 (2014-02-25)
Oxidized low-density lipoprotein (oxLDL) induces endothelial cell death through the activation of NF-κB and AP-1 pathways. TRAF3IP2 is a redox-sensitive cytoplasmic adapter protein and an upstream regulator of IKK/NF-κB and JNK/AP-1. Here we show that oxLDL-induced death in human primary
Dumindika A Siriwardane et al.
International journal of pharmaceutics, 578, 119077-119077 (2020-01-29)
Identification and quantification of excipient related degradation products in the liposomal formulation is important, as they may impact the safety and efficacy of the drug. Phospholipids are one of the major excipients in liposome drugs composing the lipid bilayer, and
Otto K Kari et al.
Nanoscale, 12(3), 1728-1741 (2020-01-03)
Methodological constraints have limited our ability to study protein corona formation, slowing nanomedicine development and their successful translation into the clinic. We determined hard and soft corona structural properties along with the corresponding proteomic compositions on liposomes in a label-free
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service